M1 Kliniken AG (DE000A0S)

BRIEF

published on 06/06/2024 at 15:27, 5 months 16 days ago

First Berlin Equity Research Increases Target Price for M1 Kliniken AG

M1 Kliniken AG 2023 Results Research Update Target Price Future Outlook
PRESS RELEASE

published on 06/06/2024 at 15:22, 5 months 16 days ago

Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research updates BUY rating on M1 Kliniken AG, raising the price target to €28 based on strong 2023 results and ambitious mid-term outlook of 150-200 M1 Beauty centers by 2029

First Berlin Equity Research M1 Kliniken AG 2023 Results BUY Rating Price Target
BRIEF

published on 06/06/2024 at 08:35, 5 months 17 days ago

M1 Kliniken AG Reports 70% EBIT Growth in Q1 2024

M1 Kliniken AG Beauty Segment EBIT Growth Q1 2024 Results Expansion Plans
PRESS RELEASE

published on 06/06/2024 at 08:30, 5 months 17 days ago

M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
M1 Kliniken AG reports impressive growth in Q1 2024, with EBIT soaring by 70%. Beauty segment fuels sales increase of 9.6%. Expansion and strong performance expected to continue

M1 Kliniken AG EBIT Growth Beauty Segment Q1 2024
BRIEF

published on 05/23/2024 at 08:35, 6 months ago

M1 Kliniken AG Reports Significant Profit Growth in 2023

M1 Kliniken AG 2023 Financial Results Market Expansion Profit Growth Aesthetic Medicine
PRESS RELEASE

published on 05/23/2024 at 08:30, 6 months ago

M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
M1 Kliniken AG reports strong profit growth in 2023, aiming for global market leadership in medical aesthetics. Annual report highlights sales increase and ambitious forecasts

M1 Kliniken AG Annual Report Forecast Profit Growth Medical Aesthetics
BRIEF

published on 05/07/2024 at 16:33, 6 months 15 days ago

M1 Kliniken AG Announces Dividend and Positive Forecast for 2024

Earnings Report M1 Kliniken AG Dividend Financial Forecast 2024 Growth
PRESS RELEASE

published on 05/07/2024 at 16:28, 6 months 15 days ago

EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
M1 Kliniken AG's Supervisory Board approves 2023 financial statements with EUR 0.50 per share dividend proposal. Anticipates sales and earnings growth in 2024

Financial Statements M1 Kliniken AG Dividend Proposal Earnings Growth 2024 Forecast
BRIEF

published on 04/30/2024 at 15:42, 6 months 22 days ago

M1 Kliniken AG Receives Positive Review on Preliminary 2023 Results from First Berlin Equity Research

First Berlin Equity Research M1 Kliniken AG Stock Recommendation Beauty Segment Performance EBIT Margins
PRESS RELEASE

published on 04/30/2024 at 15:37, 6 months 22 days ago

Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH releases a research update on M1 Kliniken AG, reiterating a BUY rating and EUR 18.00 price target, based on strong 2023 Beauty segment results and continued expansion. Contact details provided

M1 Kliniken AG BUY Rating Research Update First Berlin Equity Research GmbH EUR 18.00 Price Target

Published on 11/22/2024 at 23:55, 10 hours 31 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 10 hours 56 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 21 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 11 hours 21 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 11 hours 56 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 16 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 16 hours 26 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 16 hours 33 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 31 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 26 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 19 hours 51 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News